You Can't Get High the First Time You Smoke Weed
A persistent piece of stoner folklore that contradicts decades of pharmacology, survey data, and the experience of plenty of first-time users.
This is folklore, not pharmacology. Some first-time users genuinely don't feel much — but the reasons are mundane (poor inhalation technique, low dose, mild product, anxiety masking effects) and have nothing to do with some mystical threshold your body has to cross. Plenty of people get extremely high their first time, sometimes dangerously so. Treating 'you won't feel it' as a rule is how naive users end up greening out on edibles. Start low, go slow, regardless of what your friend told you.
The claim
Walk into any smoking circle and someone will eventually say it: "Don't worry, you don't really get high your first time. You have to learn how." The idea has been repeated for half a century. It shows up in stoner movies, on Reddit, in casual advice to nervous friends. The implied mechanism varies — sometimes it's that your receptors need to be "primed," sometimes that you have to learn to recognize the feeling, sometimes that virgin lungs can't absorb THC properly.
It is comforting advice. It is also wrong often enough that repeating it as a rule causes real harm.
What the evidence actually shows
THC is a partial agonist at the CB1 receptor Strong evidence [1]. CB1 receptors are present and functional in the human brain from birth — they don't require prior cannabis exposure to respond to cannabinoids Strong evidence [2]. There is no pharmacological mechanism by which a naive user's receptors would be unresponsive to THC.
If anything, the opposite is true. Regular cannabis users develop tolerance through CB1 receptor downregulation, meaning they need more THC to feel the same effect Strong evidence [3][4]. A daily smoker's brain is, in a real sense, less responsive to THC than a first-timer's. PET imaging studies have shown CB1 availability rebounds within weeks of abstinence Strong evidence [4].
Clinical dosing studies routinely give cannabis-naive volunteers oral or smoked THC and observe clear, dose-dependent psychoactive effects — subjective high, impaired memory, altered time perception, elevated heart rate Strong evidence [5][6]. Emergency departments see plenty of first-time users, particularly with edibles, presenting with acute intoxication, anxiety, or cannabis-induced psychosis Strong evidence [7]. They got high. They got too high.
Where the myth came from
The folklore has a partial, twisted origin in a real study. In 1968, Andrew Weil, Norman Zinberg, and Judith Nelsen published a paper in Science titled "Clinical and Psychological Effects of Marihuana in Man" [8]. They reported that nine cannabis-naive volunteers given smoked marijuana in a lab setting showed less subjective high than experienced users given the same dose — even though objective measures (heart rate, performance impairment) were similar.
That finding got compressed in popular retellings into "you don't get high the first time." What Weil and Zinberg actually documented was subtler and easier to explain: first-time users in a clinical setting didn't report feeling as high. Possible reasons include unfamiliarity with the sensation, anxiety in a lab environment, poor inhalation technique (they were new at it), and a lack of vocabulary for what they were experiencing. Later researchers have struggled to replicate the effect as cleanly Disputed, and the study used 1960s-potency cannabis at modest doses.
The study became a cultural meme. The meme outlived the data.
Why some first-timers really don't feel much
First-time users do sometimes report a weak or absent high. The reasons are practical, not mystical:
- Inhalation technique. Smoking is a learned skill. New users often don't inhale deeply or hold long enough to absorb a meaningful dose Strong evidence. This is the single most likely explanation.
- Low dose. A couple of puffs from a shared joint of mid-shelf flower might deliver only a few milligrams of absorbed THC — below the threshold for clear psychoactivity in some people.
- Anxiety and setting. Stress and unfamiliarity can mask or override the subjective "high," even when the drug is acting on the brain.
- Not knowing what to look for. The cannabis high is qualitatively different from alcohol or caffeine. Someone who expects to feel "drunk" may not register the actual effects as "high."
- Genuine individual variation. CB1 receptor density, CYP450 metabolism, and endocannabinoid tone vary between people Weak / limited [9]. A small fraction of users seem to be relatively insensitive to THC at typical doses.
None of these are "your body hasn't learned yet." They are dose, technique, expectation, and biology.
Why the myth is actively harmful
If you tell a nervous first-timer "you won't feel it anyway," you are giving them permission to take a bigger dose than they should. This is especially dangerous with edibles, where onset is delayed by 30 to 120 minutes and absorbed THC is partly converted to 11-hydroxy-THC, a more potent metabolite Strong evidence [10]. The classic edibles emergency-room visit follows exactly this script: person eats a 10 mg gummy, feels nothing after 45 minutes, eats three more, and is on the floor two hours later.
Cannabis acute intoxication is rarely physically dangerous in healthy adults, but it can be deeply unpleasant — panic, paranoia, vomiting, dissociation, occasional cardiovascular events in vulnerable people Strong evidence [7][11]. "You can't get high the first time" is a single sentence that has put a lot of people through that experience.
What to do instead
Treat your first time like any unknown drug exposure:
- Smoking or vaping flower: Start with one or two small inhales. Wait 15 minutes. Reassess. Effects from inhalation peak within about 30 minutes Strong evidence.
- Edibles: Start with 2.5 mg of THC, or 5 mg if you're confident. Wait a full two hours before considering more. See Start Low, Go Slow.
- Set and setting: Be somewhere comfortable, with someone sober or experienced, with no obligations for the next several hours.
- Have a plan if it goes sideways: Water, a quiet room, knowing that no one has ever died of a pure cannabis overdose and that the panic peaks and passes within an hour or two. CBD may blunt acute anxiety Weak / limited.
The honest version of the advice your friend should have given you: Some people don't feel much their first time, for boring reasons. Others get hit hard. You won't know which one you are until you try. So take a small amount, and find out.
Sources
- Peer-reviewed Pertwee, R. G. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta-9-tetrahydrocannabinol, cannabidiol and delta-9-tetrahydrocannabivarin. British Journal of Pharmacology, 153(2), 199-215.
- Peer-reviewed Mato, S., Del Olmo, E., & Pazos, A. (2003). Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. European Journal of Neuroscience, 17(9), 1747-1754.
- Peer-reviewed D'Souza, D. C., et al. (2008). Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology, 33(10), 2505-2516.
- Peer-reviewed Hirvonen, J., et al. (2012). Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Molecular Psychiatry, 17(6), 642-649.
- Peer-reviewed Hollister, L. E. (1986). Health aspects of cannabis. Pharmacological Reviews, 38(1), 1-20.
- Peer-reviewed Curran, H. V., Brignell, C., Fletcher, S., Middleton, P., & Henry, J. (2002). Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology, 164(1), 61-70.
- Peer-reviewed Monte, A. A., et al. (2019). Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study. Annals of Internal Medicine, 170(8), 531-537.
- Peer-reviewed Weil, A. T., Zinberg, N. E., & Nelsen, J. M. (1968). Clinical and Psychological Effects of Marihuana in Man. Science, 162(3859), 1234-1242.
- Peer-reviewed Hryhorowicz, S., et al. (2018). Pharmacogenetics of Cannabinoids. European Journal of Drug Metabolism and Pharmacokinetics, 43(1), 1-12.
- Peer-reviewed Lemberger, L., Crabtree, R. E., & Rowe, H. M. (1972). 11-hydroxy-delta-9-tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man. Science, 177(4043), 62-64.
- Government National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. The National Academies Press. ↗
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.